These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19875379)

  • 1. The effect of dialysis modality on phosphate control : haemodialysis compared to haemodiafiltration. The Pan Thames Renal Audit.
    Davenport A; Gardner C; Delaney M;
    Nephrol Dial Transplant; 2010 Mar; 25(3):897-901. PubMed ID: 19875379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized cross-over long-term comparison of online haemodiafiltration and ultrapure high-flux haemodialysis.
    Schiffl H
    Eur J Med Res; 2007 Jan; 12(1):26-33. PubMed ID: 17363355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. More dietetic time, better outcome? A randomized prospective study investigating the effect of more dietetic time on phosphate control in end-stage kidney failure haemodialysis patients.
    Morey B; Walker R; Davenport A
    Nephron Clin Pract; 2008; 109(3):c173-80. PubMed ID: 18663331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of gastric acid suppression with pantoprazole on the efficacy of calcium carbonate as a phosphate binder in haemodialysis patients.
    Cervelli MJ; Shaman A; Meade A; Carroll R; McDonald SP
    Nephrology (Carlton); 2012 Jul; 17(5):458-65. PubMed ID: 22471559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Calcium balance and intact PTH variations during haemodiafiltration.
    Argilés A; Mion CM
    Nephrol Dial Transplant; 1995 Nov; 10(11):2083-9. PubMed ID: 8643172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haemodiafiltration versus high-flux haemodialysis: Effects on phosphate control and erythropoietin response.
    Oates T; Pinney JH; Davenport A
    Am J Nephrol; 2011; 33(1):70-5. PubMed ID: 21178336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST).
    Penne EL; van der Weerd NC; van den Dorpel MA; Grooteman MP; Lévesque R; Nubé MJ; Bots ML; Blankestijn PJ; ter Wee PM;
    Am J Kidney Dis; 2010 Jan; 55(1):77-87. PubMed ID: 19962805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and side-effect profile of sevelamer hydrochloride used in combination with conventional phosphate binders.
    Sturtevant JM; Hawley CM; Reiger K; Johnson DW; Campbell SB; Burke JR; Bofinger A; Isbel NM
    Nephrology (Carlton); 2004 Dec; 9(6):406-13. PubMed ID: 15663645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low prevalence of hyperphosphatemia independent of residual renal function in peritoneal dialysis patients.
    Dong J; Wang H; Wang M
    J Ren Nutr; 2007 Nov; 17(6):389-96. PubMed ID: 17971311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RenaGel efficacy in severe secondary hyperparathyroidism.
    Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
    Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aluminum hydroxide, calcium carbonate and calcium acetate in chronic intermittent hemodialysis patients.
    Janssen MJ; van der Kuy A; ter Wee PM; van Boven WP
    Clin Nephrol; 1996 Feb; 45(2):111-9. PubMed ID: 8846523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial.
    Locatelli F; Altieri P; Andrulli S; Sau G; Bolasco P; Pedrini LA; Basile C; David S; Gazzanelli L; Tampieri G; Isola E; Marzolla O; Memoli B; Ganadu M; Reina E; Bertoli S; Ferrara R; Casu D; Logias F; Tarchini R; Mattana G; Passaghe M; Fundoni G; Villa G; Di Iorio BR; Pontoriero G; Zoccali C
    Nephrol Dial Transplant; 2014 Jun; 29(6):1239-46. PubMed ID: 24557989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Do differences in dialysis prescription impact on KDOQI bone mineral targets? The Pan Thames Renal Audit.
    Davenport A; Gardner C; Delaney M;
    Blood Purif; 2010; 30(2):111-7. PubMed ID: 20714141
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of biochemical, haematological and volume parameters in two treatment schedules of nocturnal home haemodialysis.
    Mahadevan K; Pellicano R; Reid A; Kerr P; Polkinghorne K; Agar J
    Nephrology (Carlton); 2006 Oct; 11(5):413-8. PubMed ID: 17014555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of calcium-channel blockers on calcium-phosphate metabolism in patients with end-stage renal disease.
    Lippuner K; Zehnder HJ; Casez JP; Takkinen R; Descoeudres C; Jaeger P
    Nephrol Dial Transplant; 1996 Jan; 11(1):70-4. PubMed ID: 8649655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
    Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
    Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between phosphate removal and markers of bone turnover in haemodialysis patients.
    Albalate M; de la Piedra C; Fernández C; Lefort M; Santana H; Hernando P; Hernández J; Caramelo C
    Nephrol Dial Transplant; 2006 Jun; 21(6):1626-32. PubMed ID: 16490746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Factors which influence phosphorus removal in hemodialysis].
    Gallar P; Ortiz M; Ortega O; Rodríguez I; Seijas V; Carreño A; Oliet A; Vigil A
    Nefrologia; 2007; 27(1):46-52. PubMed ID: 17402879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population.
    Rubel JR; Milford EL
    Am J Kidney Dis; 2003 Feb; 41(2):411-21. PubMed ID: 12552504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.